Skip to main content
SpringerLink
Log in

Generics do not contain branded capecitabine costs in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

Reference

  • Cole AL, et al. Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies. JAMA Internal Medicine : 11 Sep 2017. Available from: URL: http://doi.org/10.1001/jamainternmed.2017.2788

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Generics do not contain branded capecitabine costs in USA. PharmacoEcon Outcomes News 787, 17 (2017). https://doi.org/10.1007/s40274-017-4345-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4345-5

Search

Navigation